Welcome To The Stem Cell Therapeutics HUB On AGORACOM

Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.

Free
Message: What am I missing

What am I missing

posted on Jul 03, 2009 01:43PM

Why would a warrant holder exercise the option and buy at .16c when they can just buy the current shares at .16c? I could see a point if the shares were considerably higher but they aren't. All this really does is put cash is SSS's hands rather than them going to the street again for another PP>

CALGARY, ALBERTA--(Marketwire - July 2, 2009) - Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce an early warrant exercise incentive program (the "Program") designed to encourage the early exercise of up to 17,250,000 outstanding share purchase warrants (the "Warrants") for gross proceeds of up to $2,760,000. The Program will be open for a 30 day period which is anticipated to commence on July 8, 2009, and end on August 7, 2009 (the "Early Warrant Exercise Period"), subject to the approval of the TSX Venture Exchange ("TSXV"). Holders of Warrants may exercise their Warrants at a discounted price of $0.16 per Warrant during the Early Warrant Exercise Period. Prior to and following the early Warrant Exercise Period, the outstanding Warrants are exercisable to acquire common shares of the Company at a price of $0.50 per share.


Jul 04, 2009 01:17PM
1
Jul 10, 2009 04:21PM
Share
New Message
Please login to post a reply